Celltrion’s monoclonal antibody treatment for COVID-19 works against Delta variant: Study EP News Bureau Jul 16, 2021 Regdanvimab (CT-P59) also retained its neutralisation potency against the Lambda variant (C.37, first identified in Peru) using a…
Celltrion presents data for COVID-19 monoclonal antibody treatment candidate CT-P59 EP News Bureau Nov 6, 2020 It demonstrated promising safety, tolerability, antiviral effect, and efficacy profile of CT-P59 in patients with mild symptoms of…
